These data are consistent with the notion that ACE2/Ang-(1–7)/Mas receptor axis is beneficial via counter-regulating the ACE/AngII/AT1 receptor branch of the RAS which in the case of diabetes-induced vascular dysfunction exerts its detrimental actions through activation of ErbB receptors. This evidence concerns the gene ACE2 and diabetes mellitus.